checkAd

     439  0 Kommentare Teva Announces Appointment of New Chief Financial Officer

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eli Kalif as Executive Vice President and Chief Financial Officer. Mr. Kalif will begin his employment on December 22, 2019. He will be based out of Teva’s global headquarters in Israel.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191107005406/en/

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Teva Pharmaceutical Industries Ltd ADR!
    Short
    15,10€
    Basispreis
    1,34
    Ask
    × 9,13
    Hebel
    Long
    12,45€
    Basispreis
    1,37
    Ask
    × 7,52
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Eli Kalif, appointed CFO of Teva Pharmaceutical Industries (Photo: Business Wire)

    Eli Kalif, appointed CFO of Teva Pharmaceutical Industries (Photo: Business Wire)

    Mr. Kalif joins Teva with broad experience in corporate and operational finance,  most recently as Senior Vice President, Finance, leading the finance organization that supports the Global Operations, Components & services business at Flex Ltd. (NASDAQ: FLEX), a global technology design and manufacturing service provider with extensive operations that include 85 production sites in 30 countries.

    "Eli brings to Teva more than 20 years of leadership roles with a proven track record in complex financial organizations, where he was responsible for leading global teams supporting multi-billion-dollar operations within a dynamic market environment," said Kåre Schultz, Teva's President and CEO. "He possesses a profound understanding of global production structures and has experience in leading organizational transformation, as well as building world class financial organizations. With deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning and accounting, I believe Eli has the required leadership capabilities to strategically manage our debt, enabling the company to move forward from the restructuring phase to optimizing Teva for success and future sustainable growth."

    Mr. Kalif stated, "I look forward to joining Teva's leadership team and leading its finance organization to contribute to Teva's future success as the company progresses to the next phase of its strategy."

    Kåre Schultz, Teva’s President and CEO, will perform the functions of the Company’s chief financial officer from the date of Mr. McClellan’s departure on November 8, 2019 until Mr. Kalif begins employment with the Company on December 22, 2019.

    Eli Kalif bio

    Eli Kalif has held senior positions at Flex Ltd, a US-based global technology design and manufacturing service provider, with annual revenues of approximately $25 billion. His most recent position was Senior Vice President Finance Global Operations, Components & Services, which he has held since 2013, and he previously served as Vice President of Finance for the Americas as well as in Europe & South America.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Teva Announces Appointment of New Chief Financial Officer Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eli Kalif as Executive Vice President and Chief Financial Officer. Mr. Kalif will begin his employment on December 22, 2019. He will be based out of Teva’s …

    Schreibe Deinen Kommentar

    Disclaimer